Back to top
more

Exscientia (EXAI)

(Delayed Data from NSDQ)

$5.28 USD

5.28
422,064

-0.03 (-0.56%)

Updated Nov 7, 2024 04:00 PM ET

After-Market: $5.30 +0.02 (0.38%) 6:40 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 251)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Balance Sheet

Research for EXAI

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Exscientia PLC Sponsored ADR falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 452 626 773 80 -99,999
Receivables 52 60 26 8 NA
Notes Receivable 0 0 0 0 NA
Inventories 0 0 0 0 NA
Other Current Assets 0 0 0 0 NA
Total Current Assets 504 685 800 89 NA
Net Property & Equipment 61 47 12 6 NA
Investments & Advances 3 3 4 0 NA
Other Non-Current Assets 1 0 0 0 NA
Deferred Charges 1 1 0 0 NA
Intangibles 43 49 58 0 NA
Deposits & Other Assets 0 0 0 0 NA
Total Assets 635 804 881 100 NA
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 NA
Accounts Payable 14 38 9 4 NA
Current Portion Long-Term Debt 0 0 0 0 NA
Current Portion Capital Leases 3 3 1 1 NA
Accrued Expenses 0 0 0 0 NA
Income Taxes Payable 0 0 0 0 NA
Other Current Liabilities 64 72 53 14 NA
Total Current Liabilities 81 113 63 19 NA
Mortgages 0 0 0 0 NA
Deferred Taxes/Income 7 9 10 0 NA
Convertible Debt 0 0 0 0 NA
Long-Term Debt 0 0 0 0 NA
Non-Current Capital Leases 20 14 5 4 NA
Other Non-Current Liabilities 84 75 23 2 NA
Minority Interest (Liabilities) 0 0 0 0 NA
Total Liabilities 193 211 102 25 NA
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 NA
Common Stock (Par) 0 0 0 0 NA
Capital Surplus 454 451 501 114 NA
Retained Earnings -137 29 187 -44 NA
Other Equity 126 113 91 4 NA
Treasury Stock 0 0 0 0 NA
Total Shareholder's Equity 442 592 779 75 NA
Total Liabilities & Shareholder's Equity 635 804 881 100 NA
Total Common Equity 442 592 779 75 0
Shares Outstanding 120.80 122.80 117.90 NA NA
Book Value Per Share 3.66 4.82 6.61 0.00 0.00

Fiscal Year End for Exscientia PLC Sponsored ADR falls in the month of December.

All items in Millions except Per Share data.

9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023
Assets          
Cash & Equivalents -99,999 370 418 452 464
Receivables NA 60 53 52 97
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 0 0 0 0
Total Current Assets NA 429 471 504 561
Net Property & Equipment NA 56 60 61 63
Investments & Advances NA 3 3 3 3
Other Non-Current Assets NA 1 1 1 1
Deferred Charges NA 1 1 1 1
Intangibles NA 40 42 43 45
Deposits & Other Assets NA 0 0 0 0
Total Assets NA 553 601 635 696
Liabilities & Shareholders Equity 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 10 9 14 13
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 5 3 3 3
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 58 62 64 68
Total Current Liabilities NA 72 75 81 84
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 6 7 7 8
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 21 21 20 20
Other Non-Current Liabilities NA 78 84 87
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 179 181 193 199
Shareholders Equity 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 460 462 454 462
Retained Earnings NA -199 -159 -137 -92
Other Equity NA 113 115 126 128
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 374 419 442 497
Total Liabilities & Shareholder's Equity NA 553 601 635 696
Total Common Equity 0 374 419 442 497
Shares Outstanding 120.80 120.80 120.80 120.80 120.80
Book Value Per Share 0.00 3.09 3.47 3.66 4.12